Financhill
Buy
60

MBOT Quote, Financials, Valuation and Earnings

Last price:
$2.15
Seasonality move :
-16.21%
Day range:
$2.00 - $2.16
52-week range:
$0.82 - $3.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.56x
Volume:
2.1M
Avg. volume:
7M
1-year change:
73.39%
Market cap:
$36.4M
Revenue:
--
EPS (TTM):
-$0.80

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Microbot Medical has 318.61% upside to fair value with a price target of $9.00 per share.

MBOT vs. S&P 500

  • Over the past 5 trading days, Microbot Medical has overperformed the S&P 500 by 4.94% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Microbot Medical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Microbot Medical revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Microbot Medical reported revenues of --.

Earnings Growth

  • Microbot Medical has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Microbot Medical reported earnings per share of -$0.20.
Enterprise value:
32.1M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-3.57x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$14.2M -$11M -$10.5M -$2.5M -$3.3M
EBITDA -$14.1M -$10.9M -$10.4M -$2.5M -$3.3M
Diluted EPS -$1.97 -$1.20 -$0.80 -$0.21 -$0.20
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $26.9M $18.8M $6.6M $8.4M $5M
Total Assets $28M $19.7M $7.4M $8.9M $5.2M
Current Liabilities $919K $1.4M $1.7M $1.5M $1.4M
Total Liabilities $1.5M $1.8M $1.9M $1.5M $1.4M
Total Equity $26.5M $17.9M $5.5M $7.4M $3.8M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$12M -$9.2M -$9M -$1.7M -$2.8M
Cash From Investing $2.9M -$4.7M $3M -$2.6M $140K
Cash From Financing -- $10.9M $5.1M -$161K $633K
Free Cash Flow -$12.1M -$9.2M -$9M -$1.7M -$2.8M
MBOT
Sector
Market Cap
$36.4M
$43.3M
Price % of 52-Week High
63.61%
47.98%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
73.39%
-36.92%
Beta (5-Year)
1.512
0.753
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $2.14
200-day SMA
Buy
Level $1.13
Bollinger Bands (100)
Buy
Level 0.76 - 1.74
Chaikin Money Flow
Sell
Level -761.4M
20-day SMA
Buy
Level $1.98
Relative Strength Index (RSI14)
Buy
Level 56.09
ADX Line
Buy
Level 39.38
Williams %R
Neutral
Level -53.6842
50-day SMA
Buy
Level $1.56
MACD (12, 26)
Buy
Level 0.17
25-day Aroon Oscillator
Sell
Level -16
On Balance Volume
Neutral
Level 980.6M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Stock Forecast FAQ

In the current month, MBOT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MBOT average analyst price target in the past 3 months is $9.00.

  • Where Will Microbot Medical Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Microbot Medical share price will rise to $9.00 per share over the next 12 months.

  • What Do Analysts Say About Microbot Medical?

    Analysts are divided on their view about Microbot Medical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Microbot Medical is a Sell and believe this share price will drop from its current level to $9.00.

  • What Is Microbot Medical's Price Target?

    The price target for Microbot Medical over the next 1-year time period is forecast to be $9.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MBOT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Microbot Medical is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MBOT?

    You can purchase shares of Microbot Medical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Microbot Medical shares.

  • What Is The Microbot Medical Share Price Today?

    Microbot Medical was last trading at $2.15 per share. This represents the most recent stock quote for Microbot Medical. Yesterday, Microbot Medical closed at $2.15 per share.

  • How To Buy Microbot Medical Stock Online?

    In order to purchase Microbot Medical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 110x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Buy
58
UPST alert for Feb 13

Upstart Holdings [UPST] is up 31.82% over the past day.

Buy
79
CFLT alert for Feb 13

Confluent [CFLT] is up 24.92% over the past day.

Buy
52
BL alert for Feb 13

BlackLine [BL] is down 18.03% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock